5% Off
5% Off
marketed by IPCA LABORATORIES LTD.
• 10TAB
₹110.72
M.R.P.: ₹116.55
5% Off
Inclusive of all taxes
GLYCINORM M tablet belongs to a class of drugs known as anti-diabetic drugs. it is a combination of two drugs used to treat type 2 diabetes in adults. it helps control blood sugar levels in people with diabetes. this tablet is a combination of two antidiabetic drugs: gliclazide and metformin. gliclazide is a sulfonyl urease drug that works by increasing the amount of insulin released by the pa
hypersensitivity to GLYCINORM M diabetic keto acidosis impaired kidney function.
babies: not applicable.
lactating mothers: this tablet is probably safe to use during breastfeeding.
limited human data suggests that the drug does not represent any significant risk to the baby.
pregnancy: this tablet may be unsafe to use during pregnancy.
there are limited studies in humans; animal studies have shown harmful effects on the developing baby.
please consult your doctor.
driving: your ability to drive may be affected if your blood sugar is too low or too high.
do not drive if these symptoms occur.
alcohol: it is unsafe to consume alcohol with this tablet.
kidney: this tablet should be used with caution in patients with kidney disease.
dose adjustment of this tablet may be needed.
please consult your doctor.
the use of this tablet is, however, not recommended in patients with severe kidney disease.
regular monitoring of kidney function tests is advisable while you are taking this medicine.
liver: this tablet should be used with caution in patients with liver disease.
dose adjustment of this tablet may be needed.
please consult your doctor.
this tablet is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease..
Hypoglycemia (low blood glucose level) Taste change Nausea Diarrhea Stomach pain Headache Upper respiratory tract infection.
GLYCINORM M tablet is a combination of two antidiabetic drugs: gliclazide and metformin.
gliclazide is a sulfonyl urease drug that works by increasing the amount of insulin released by the pancreas to lower blood sugar levels.
metformin is a biguanide that reduces glucose production in the liver, slows the absorption of glucose by the intestines, and increases the body's sensitivity to insulin..
If you miss a dose, take GLYCINORM M as soon as possible.
If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily.
Don't double the dose to catch up with the missed dose..
• monitor your blood sugar levels regularly while you are taking GLYCINORM M
• may cause hypoglycemia (low blood sugar) when used with other anti-diabetic drugs, alcohol, or if you skip meals
• take plenty of water while taking this tablet.
it may cause dehydration
• tell your doctor about diabetes treatment if you are going to have surgery under general anaesthesia
• tell your doctor right away if you experience deep or rapid breathing, or if you experience long-term nausea, vomiting, and stomach pain, because this tablet may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid that works in the blood
• your doctor may check your liver function regularly.
tell your doctor if you have symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
• if you missed a dose, don’t go for a double dose; please consult your doctor.
contraindicated • metformin + acetriozoate sodium: concurrent use may lead to lactic acidosis and acute renal failure • metformin + lobitridol: concurrent use may lead to lactic acidosis and acute renal failure • metformin + tyropanoate sodium: concurrent use may lead to lactic acidosis and acute renal failure • metformin + metrizamide: concurrent use may lead to lactic acidosis and acute renal failure major • metformin + acetylsalicyclium acidum: concurrent use may lead to increased risk of hypoglycemia • metformin + aspirin: concurrent use may lead to increased risk of hypoglycemia • metformin + bupropion: concurrent use may lead to reduced renal clearance of oct2 substrates.
100% Authentic
Easy Return